Press Release

Erytech Pharma: Monthly Information Related to Total Number of Voting Rights and Shares Composing the Share Capital – January 31, 2018

Article 223-16 of general regulation of French Autorité des Marchés Financiers

LYON, France--(BUSINESS WIRE)--Feb. 12, 2018--

Regulatory News:

Erytech Pharma (Euronext: ERYP- Nasdaq: ERYP):

Listing markets:
Euronext Paris from Euronext (Market segment B - ISIN Code: FR0011471135- Symbol : ERYP) &
Nasdaq Global Select Market in the United-States (Symbol : ERYP)
Website :


Total of shares composing
the share capital


Total of brut(1) voting


Total of net(2) voting

December 31, 2017   17 937 559   19 545 443   19 542 943
January 1, 2018   17 940 035(3)   19 543 919(3)   19 541 419

(1) Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
(2) Without treasury shares
(3) The number of shares and voting rights increased due to issuance of shares consequently to warrants exercises and or end of vesting periods of free shares which a Board of Director will take notice of in the future.

Source: Erytech Pharma

Erytech Pharma